Secukinumab

Common brands: Cosentyx, Methotrexate, Rasuvo, Otrexup, Trexall

Top reporter: Novartis Pharmaceuticals Corporation

Interleukin-17A Antagonist [EPC]Folate Analog Metabolic Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Tumor Necrosis Factor Blocker [EPC]Corticosteroid [EPC]
158,767
Total Reports
68,217
Serious Reports
8,114
Death Reports
30
Reported Reactions
Death Report Ratio: High (5.11%)

Patient Demographics

Male
55,771
Female
91,447

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Secukinumab.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 28,950
11.4%
2 PSORIASIS 22,709
8.9%
3 PAIN 16,387
6.5%
4 ARTHRALGIA 14,685
5.8%
5 FATIGUE 10,379
4.1%
6 PSORIATIC ARTHROPATHY 9,987
3.9%
7 PRURITUS 9,301
3.7%
8 MALAISE 9,286
3.7%
9 RASH 8,890
3.5%
10 CONDITION AGGRAVATED 8,349
3.3%
11 DIARRHOEA 7,840
3.1%
12 NASOPHARYNGITIS 7,647
3.0%
13 PAIN IN EXTREMITY 7,208
2.8%
14 HEADACHE 7,101
2.8%
15 OFF LABEL USE 6,547
2.6%
16 JOINT SWELLING 6,468
2.5%
17 MUSCULOSKELETAL STIFFNESS 6,267
2.5%
18 NAUSEA 6,211
2.4%
19 PERIPHERAL SWELLING 5,391
2.1%
20 PYREXIA 5,331
2.1%
21 ABDOMINAL DISCOMFORT 5,161
2.0%
22 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5,054
2.0%
23 PNEUMONIA 5,001
2.0%
24 HYPERSENSITIVITY 5,000
2.0%
25 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4,940
1.9%
26 ALOPECIA 4,880
1.9%
27 RHEUMATOID ARTHRITIS 4,880
1.9%
28 PRODUCT DOSE OMISSION ISSUE 4,778
1.9%
29 SWELLING 4,755
1.9%
30 DYSPNOEA 4,667
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.